1.
Golbakhsh M, Jamshidof M, Heydari A, Talebiyan P, Baghbani S, Ebrahimian M, Rastegar M. The Likelihood of Wound Complications Following the Use of Rivaroxaban as a Thrombo-Prophylactic Agent in Patients Undergoing Spinal Canal Stenosis Surgery: A Case Series. J Orthop Spine Trauma. 2022;8(4):130-3.